Multiple sclerosis: the disease and its manifestations

Area of Science:

• Neurology
• Immunology
• Neuroscience

Background:

• Multiple sclerosis (MS) is an immune-mediated inflammatory demyelinating disease of the central nervous system.
• It is characterized by relapses and remissions of neurological disturbance, with a typical relapse resolving over several months.
• While clinical recovery can be complete early on, persistent conduction and structural abnormalities are detectable.

Purpose of the Study:

• To describe the clinical characteristics and disease course of multiple sclerosis.
• To highlight diagnostic methods and the progression of neurological deficits.
• To explore the relationship between cognitive disturbances and disease severity.

Main Methods:

• Clinical observation of disease progression, including relapses and remissions.
• Utilizing evoked potential techniques and magnetic resonance imaging (MRI) to detect abnormalities.
• Cerebrospinal fluid (CSF) examination for oligoclonal IgG.

Main Results:

• Neurological deficit accumulates over years, often leading to a phase of continuous disability progression.
• Cognitive disturbances, including attention, memory, and executive skill deficits, are common and can be prominent.
• Correlation exists between cerebral white matter MRI abnormalities and cognitive deficit severity, with rarer psychotic symptoms linked to white matter disease.

Conclusions:

• Multiple sclerosis diagnosis is primarily clinical, supported by neuroimaging and CSF analysis.
• Cognitive impairment is a significant feature, often correlating with MRI findings.
• Disease progression involves accumulating deficits and potential cognitive decline, with mood disturbances also being common.